• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喷司他丁与α干扰素治疗脾切除的毛细胞白血病患者的比较:一项组间研究。癌症与白血病B组及西南肿瘤协作组

Comparison of pentostatin and alpha interferon in splenectomized patients with active hairy cell leukemia: an intergroup study. Cancer and Leukemia Group B and South-West Oncology Group.

作者信息

Rai K R

机构信息

Division of Hematology/Oncology, Long Island Jewish Medical Center, New Hyde Park, New York 11042.

出版信息

Leuk Lymphoma. 1994;14 Suppl 1:107-8.

PMID:7820040
Abstract

In 90 splenectomized patients with active HCL, this multi-institutional intergroup study showed that as compared to alpha interferon (aIF), pentostatin resulted in a higher incidence of response, but the difference was not statistically significantly. Pentostatin-induced remissions occurred significantly faster and such responses lasted significantly longer when compared with aIF induced remissions. there were no unusual toxicities observed in this study. This study confirms previous observations that both these agents have important place in therapy of hairy cell leukemia.

摘要

在90例患有活动性毛细胞白血病(HCL)的脾切除患者中,这项多机构组间研究表明,与α干扰素(aIF)相比,喷司他丁导致缓解的发生率更高,但差异无统计学意义。与aIF诱导的缓解相比,喷司他丁诱导的缓解出现得明显更快,且这种缓解持续的时间明显更长。在本研究中未观察到异常毒性。这项研究证实了先前的观察结果,即这两种药物在毛细胞白血病的治疗中都占有重要地位。

相似文献

1
Comparison of pentostatin and alpha interferon in splenectomized patients with active hairy cell leukemia: an intergroup study. Cancer and Leukemia Group B and South-West Oncology Group.喷司他丁与α干扰素治疗脾切除的毛细胞白血病患者的比较:一项组间研究。癌症与白血病B组及西南肿瘤协作组
Leuk Lymphoma. 1994;14 Suppl 1:107-8.
2
Treatment of hairy cell leukaemia.毛细胞白血病的治疗。
Lancet. 1990 Jul 21;336(8708):149-50.
3
Hairy cell leukemia. Current management.
Hematol Oncol Clin North Am. 1990 Apr;4(2):489-502.
4
Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.喷司他丁治疗初始重组α干扰素治疗失败的毛细胞白血病患者:癌症与白血病B组研究8515报告
Leukemia. 1994 Dec;8(12):2037-40.
5
Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.喷司他丁与α-2a干扰素治疗初治毛细胞白血病患者的随机对照研究:一项协作组研究
J Clin Oncol. 1995 Apr;13(4):974-82. doi: 10.1200/JCO.1995.13.4.974.
6
Hairy cell leukemia. A therapeutical update.
Haematologica. 1989 Mar-Apr;74(2):205-18.
7
[Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].[毛细胞白血病患者行脾切除术、α-干扰素及脱氧助间霉素治疗的结果]
Srp Arh Celok Lek. 2000 Jul-Aug;128(7-8):262-70.
8
Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha.
Am J Hematol. 1990 Mar;33(3):205-9. doi: 10.1002/ajh.2830330309.
9
Clinical trials in hairy cell leukemia. Current status and future directions.毛细胞白血病的临床试验。现状与未来方向。
Ann Intern Med. 1987 Jun;106(6):871-8. doi: 10.7326/0003-4819-106-6-871.
10
Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).喷司他丁(2'-脱氧助间型霉素)治疗毛细胞白血病的缓解情况。
N Engl J Med. 1987 Apr 2;316(14):825-30. doi: 10.1056/NEJM198704023161401.